Healthcare Services

Chemiluminescence Immunoassay Market (2026–2030): Innovation and Competitive Analysis

April 20, 2026April 20, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Is The Forecasted Market Size Trajectory Of The Chemiluminescence Immunoassay Market From 2026 To 2030?

The chemiluminescence immunoassay market has experienced substantial growth in recent years. It is projected to expand from $14.85 billion in 2025 to $16.15 billion in 2026, achieving a compound annual growth rate (CAGR) of 8.8%. This historical growth can be linked to the increasing occurrence of infectious and chronic diseases, the expansion of centralized diagnostic laboratories, a heightened demand for accurate biomarker detection, the broader adoption of automated laboratory systems, and the growing application of immunoassays in clinical diagnostics.

The chemiluminescence immunoassay market size is anticipated to undergo significant expansion over the next few years. Projections indicate it will reach $22.35 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 8.5%. This growth throughout the forecast period stems from factors such as increasing demand for early disease detection, rising adoption of personalized medicine diagnostics, expansion of decentralized testing models, growing integration of AI-assisted diagnostic interpretation, and increasing investment in advanced clinical laboratory infrastructure. Furthermore, major trends for this period include increasing adoption of fully automated immunoassay analyzers, rising demand for high-sensitivity diagnostic kits, growing use of multiplex testing capabilities, expansion of rapid and point-of-care CLIA systems, and an enhanced focus on standardized reagent performance.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/report/chemiluminescence-immunoassay-global-market-report

Which Key Drivers Are Affecting The Chemiluminescence Immunoassay Market Development?

The increasing incidence of infectious diseases is anticipated to fuel the expansion of the chemiluminescence immunoassay market in the future. Infectious diseases are defined as illnesses resulting from detrimental microorganisms like bacteria, viruses, fungi, or parasites, which can be transmitted between individuals either directly or indirectly. The rising occurrence of these diseases is linked to an increase in antimicrobial resistance, which renders typical treatments ineffective, allowing infections to persist and spread. Chemiluminescence immunoassays are instrumental in diagnosing infectious diseases by offering highly sensitive and specific detection of biomarkers, facilitating the prompt and precise identification of pathogens. These assays also minimize diagnostic delays through their rapid and dependable results, enhancing patient care and therapeutic outcomes. For instance, in February 2024, the UK Health Security Agency, a UK-based government body, reported that tuberculosis cases in England climbed to 4,850 in 2023, marking a 10.7% rise from 4,380 cases in 2022. Consequently, the escalating prevalence of infectious diseases is propelling the growth of the chemiluminescence immunoassay market.

Which Segment Categories Are Included In The Chemiluminescence Immunoassay Market Segment Analysis?

The chemiluminescence immunoassay market covered in this report is segmented –

1) By Product Type: Analyzers, Kits, Reagents

2) By Sample Type: Blood, Saliva, Urine, Other Samples

3) By Technology: Chemiluminescence Enzyme Technology (CLEIA), Electrochemiluminescence Immunoassay (ECLI), Microparticle Chemiluminescence Immunoassay

4) By Application: Therapeutic Drug Monitoring, Oncology, Cardiology, Endocrinology, Infectious Disease, Autoimmune Disease, Other Applications

5) By End-User: Hospitals, Pharmaceutical And Biotechnology Companies, Clinical Laboratories, Other End-Users

Subsegments:

1) By Analyzers: Fully Automated Analyzers, Semi Automated Analyzers, Portable Analyzers

2) By Kits: Detection Kits, Quantitative Kits, Qualitative Kits, Multiparameter Kits

3) By Reagents: Luminol Reagents, Isoluminol Reagents, Acridinium Ester Reagents, Other Reagents

What Trends Are Transforming The Chemiluminescence Immunoassay Market?

Leading companies operating in the chemiluminescence immunoassay market are focusing on the development of advanced products, such as sophisticated chemiluminescence immunoassay analyzers, to improve test accuracy, boost throughput, and deliver faster diagnostic outcomes for a wide array of clinical applications. Chemiluminescence immunoassay analyzers are automated instruments designed to detect and quantify light emitted during chemical reactions, accurately identifying specific biomarkers in diagnostic tests. For instance, in July 2023, Fapon Biotech Inc., a biotechnology company based in China, introduced the Shine i8000/9000, a chemiluminescence immunoassay analyzer. This device is engineered for medium to large laboratories, offering quick preliminary results within 10 minutes and high precision, featuring a compact, stable, and user-friendly design. Its prominent features include a 360-degree large-span display, one-touch bulk loading for reaction cups, a dual-tube backup substrate system, and automatic reaction cup disposal to minimize contamination. The fully automated workflow reduces manual intervention, while advanced algorithms improve result consistency, making it well-suited for high-volume diagnostic environments.

Who Are The Active Companies Shaping The Chemiluminescence Immunoassay Market?

Major companies operating in the chemiluminescence immunoassay market are F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Shenzhen Mindray Bio-Medical Electronics Co. Ltd., QuidelOrtho Corporation, Sysmex Corporation, Bio-Rad Laboratories Inc., Revvity Inc., DiaSorin S.p.A., Tecan Group Ltd., Euroimmun AG, Randox Laboratories Ltd., Autobio Diagnostics Co. Ltd., Wondfo Biotech Co. Ltd., Fujirebio Diagnostics Inc., Trivitron Healthcare Pvt. Ltd., Getein Biotech Inc., Fapon Biotech Inc., Diazyme Laboratories Inc.

Get The Full Chemiluminescence Immunoassay Market Report:

https://www.thebusinessresearchcompany.com/report/chemiluminescence-immunoassay-global-market-report

Which Region Dominates The Chemiluminescence Immunoassay Market By Market Share?

North America was the largest region in the chemiluminescence immunoassay market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the chemiluminescence immunoassay market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Chemiluminescence Immunoassay Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/chemiluminescence-immunoassay-global-market-report

Browse Through More Reports Similar to the Global Chemiluminescence Immunoassay Market 2026, By The Business Research Company

Services Procurement Market Report 2026

https://www.thebusinessresearchcompany.com/report/services-procurement-global-market-report

Commercial Services Market Report 2026

https://www.thebusinessresearchcompany.com/report/commercial-services-global-market-report

Legal Services Market Report 2026

https://www.thebusinessresearchcompany.com/report/legal-services-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795